ArticleCancers2020

Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells.

Hiroki Akiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.